Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;26(4):243-244.
doi: 10.1136/ejhpharm-2019-001975. Epub 2019 Jun 14.

Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?

Antonella Nappi  1 , Alessandro Perrella  2 , Luca Rinaldi  3 , Antonio Izzi  4 , Rodolfo Punzi  4 , Luigi Elio Adinolfi  3 , Costanza Sbeglia  2 , Pasquale Bellopede  2 , Adelaide Maddaloni  2 , Nunzia Papa  1 , Micaela Spatarella  1
Affiliations

Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?

Antonella Nappi et al. Eur J Hosp Pharm. 2019 Jul.
No abstract available

Keywords: ADR; DAAs; HCC; HCV; antiviral; cirrhosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Jakobsen JC, Nielsen EE, Feinberg J, et al. . Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst Rev 2017;6 10.1002/14651858.CD012143.pub2 - DOI - PMC - PubMed
    1. Yin S, Barker L, White JZ, et al. . Sofosbuvir-based regimens for chronic hepatitis C in a well-insured U.S. population: patient characteristics, treatment adherence, effectiveness, and health care costs, 2013–2015. J Manag Care Spec Pharm 2019;25:195–210. 10.18553/jmcp.2019.25.2.195 - DOI - PMC - PubMed
    1. Roche B, Coilly A, Duclos-Vallee JC, et al. . The impact of treatment of hepatitis C with DAAs on the occurrence of HCC. Liver Int 2018;38(Suppl1):139–45. 10.1111/liv.13659 - DOI - PubMed
    1. Nappi A, Perrella A, Bellopede P, et al. . Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist. Infect Agent Cancer 2017;12:12–12.. Feb 7 10.1186/s13027-017-0119-8 - DOI - PMC - PubMed
    1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255–9. 10.1016/S0140-6736(00)02799-9 - DOI - PubMed